Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
SLCO1B1 variants and the risk of antituberculosis drug-induced hepatotoxicity: a systematic review and meta-analysis.
Pharmacogenomics. 2023 Dec;24(18):931-942. doi: 10.2217/pgs-2023-0168. Epub 2023 Nov 29.
Pharmacogenomics. 2023.
PMID: 38019119
Review.
A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population.
Zhu J, Liu W, Zhang M, Lu L, Pan H, He X, Wang N, Yang M, Yi H, Tang S.
Zhu J, et al.
J Clin Pharm Ther. 2021 Oct;46(5):1288-1294. doi: 10.1111/jcpt.13452. Epub 2021 May 27.
J Clin Pharm Ther. 2021.
PMID: 34046917
Item in Clipboard
The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury.
Zhang M, Zhu J, Wang N, Liu W, Lu L, Pan H, He X, Yi H, Tang S.
Zhang M, et al.
J Clin Pharm Ther. 2022 Aug;47(8):1276-1283. doi: 10.1111/jcpt.13672. Epub 2022 Apr 25.
J Clin Pharm Ther. 2022.
PMID: 35470464
Item in Clipboard
Relationship between common telomere length-related genetic variations, telomere length, and risk of antituberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method.
Chen X, Hao Z, Pan H, Liu W, Lu L, Zhang M, He X, Yi H, Tang S.
Chen X, et al.
Fundam Clin Pharmacol. 2023 Aug;37(4):858-867. doi: 10.1111/fcp.12885. Epub 2023 Mar 7.
Fundam Clin Pharmacol. 2023.
PMID: 36855016
Item in Clipboard
Cite
Cite